CD8


Journal

Journal of immunology (Baltimore, Md. : 1950)
ISSN: 1550-6606
Titre abrégé: J Immunol
Pays: United States
ID NLM: 2985117R

Informations de publication

Date de publication:
01 01 2022
Historique:
received: 01 07 2021
accepted: 22 10 2021
pubmed: 26 11 2021
medline: 12 1 2022
entrez: 25 11 2021
Statut: ppublish

Résumé

Ag-specific immunotherapy is a long-term goal for the treatment of autoimmune diseases; however developing a means of therapeutically targeting autoimmune T cells in an Ag-specific manner has been difficult. Through the engineering of an HLA-DR1 chimeric Ag receptor (CAR), we have produced CD8

Identifiants

pubmed: 34819392
pii: jimmunol.2100643
doi: 10.4049/jimmunol.2100643
pmc: PMC8702470
mid: NIHMS1751337
doi:

Substances chimiques

HLA-DR1 Antigen 0
Receptors, Chimeric Antigen 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

16-26

Subventions

Organisme : NIAMS NIH HHS
ID : R21 AR071633
Pays : United States

Informations de copyright

Copyright © 2021 by The American Association of Immunologists, Inc.

Références

Nat Med. 2015 Jun;21(6):581-90
pubmed: 25939063
Science. 2002 Oct 25;298(5594):850-4
pubmed: 12242449
Transfus Med Hemother. 2019 Feb;46(1):15-24
pubmed: 31244578
Blood. 2011 Nov 3;118(18):4817-28
pubmed: 21849486
Nat Rev Rheumatol. 2014 Oct;10(10):612-27
pubmed: 25112605
Nat Biotechnol. 2018 Sep;36(8):707-716
pubmed: 29985479
J Gen Virol. 2001 May;82(Pt 5):1013-1025
pubmed: 11297676
J Exp Med. 1997 Mar 17;185(6):1113-22
pubmed: 9091584
Arthritis Rheum. 1989 Jan;32(1):15-21
pubmed: 2492197
J Immunol. 2002 Jan 1;168(1):253-9
pubmed: 11751969
Blood. 2010 Nov 11;116(19):3875-86
pubmed: 20631379
J Clin Invest. 2020 Jun 1;130(6):3087-3097
pubmed: 32069268
J Immunol. 1998 Mar 15;160(6):2573-8
pubmed: 9510154
N Engl J Med. 2014 Oct 16;371(16):1507-17
pubmed: 25317870
Nature. 1993 Jul 1;364(6432):33-9
pubmed: 8316295
Nat Cancer. 2021 Jun;2(6):629-642
pubmed: 34345830
Exp Hematol Oncol. 2019 Nov 5;8:27
pubmed: 31709128
Int J Biol Sci. 2019 Sep 7;15(12):2548-2560
pubmed: 31754328
Mol Ther. 2017 Feb 1;25(2):456-464
pubmed: 28109957
Nat Med. 2017 Jan 6;23(1):18-27
pubmed: 28060797
Annu Rev Immunol. 2003;21:659-84
pubmed: 12615890
Nat Clin Pract Oncol. 2006 Dec;3(12):668-81
pubmed: 17139318
J Immunol Methods. 1983 Dec 16;65(1-2):55-63
pubmed: 6606682
Science. 1991 Dec 20;254(5039):1788-91
pubmed: 1763329
Science. 2016 Jul 8;353(6295):179-84
pubmed: 27365313
J Exp Med. 1981 May 1;153(5):1198-214
pubmed: 6166712
Curr Protoc Immunol. 2010 Apr;Chapter 15:Unit 15.5.1-25
pubmed: 20376842
Arthritis Res Ther. 2014 Jan 10;16(1):R7
pubmed: 24405551
Sci Signal. 2018 Aug 21;11(544):
pubmed: 30131370
Front Immunol. 2018 Nov 08;9:2593
pubmed: 30467505
Biomedicines. 2021 Jan 09;9(1):
pubmed: 33435454
Proc Natl Acad Sci U S A. 2018 Nov 13;115(46):E10898-E10906
pubmed: 30373813
J Clin Invest. 2016 Aug 1;126(8):3130-44
pubmed: 27454297
Immunol Rev. 2015 Jan;263(1):68-89
pubmed: 25510272
J Immunol. 2010 Jul 1;185(1):110-8
pubmed: 20511555
Arthritis Rheum. 2005 Apr;52(4):1063-8
pubmed: 15818663
Blood. 2011 Dec 1;118(23):6050-6
pubmed: 21984804
Curr Opin Immunol. 2005 Apr;17(2):195-201
pubmed: 15766681
Mol Ther. 2018 Dec 5;26(12):2727-2737
pubmed: 30309819
J Control Release. 2013 Dec 10;172(2):426-35
pubmed: 23770010
J Autoimmun. 2019 Jan;96:50-58
pubmed: 30122420
J Immunol Methods. 1986 May 22;89(2):271-7
pubmed: 3486233
Autoimmun Rev. 2012 Aug;11(10):754-65
pubmed: 22387972
Genome Biol. 2017 Apr 27;18(1):76
pubmed: 28449694
JCI Insight. 2018 Jan 11;3(1):
pubmed: 29321369
J Immunol. 2006 Sep 15;177(6):3884-92
pubmed: 16951351
J Immunol. 2005 Apr 1;174(7):3978-85
pubmed: 15778354
Nat Commun. 2021 Jan 29;12(1):710
pubmed: 33514714

Auteurs

Karen B Whittington (KB)

Veterans Affairs Medical Center, Memphis TN.

Amanda Prislovsky (A)

Veterans Affairs Medical Center, Memphis TN.

Jacob Beaty (J)

Department of Medicine, University of Tennessee Health Science Center, Memphis TN.

Lorraine Albritton (L)

Department of Microbiology, Immunology and Biochemistry, University of Tennessee Health Science Center, Memphis TN; and.

Marko Radic (M)

Department of Microbiology, Immunology and Biochemistry, University of Tennessee Health Science Center, Memphis TN; and.

Edward F Rosloniec (EF)

Veterans Affairs Medical Center, Memphis TN; erosloniec@uthsc.edu.
Department of Medicine, University of Tennessee Health Science Center, Memphis TN.
Department of Pathology, University of Tennessee Health Science Center, Memphis TN.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH